Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

24-Oct-2011

  • PSA test valuable in predicting biopsy need, low-risk prostate cancer, study finds

    The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a new study has found.


  • Prostate Cancer: Why Men Will Likely Ignore the Calls to Skip PSA Tests

    In our war against cancer, men don't hear about the downsides of screening


  • PSA test predicts biopsy need and prostate cancer development

    The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, Calif.


  • Back to Prostate News Archive